Response to: Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al

Susan Aungier; Alison J. Cartwright; Anja Schwenzer; Jennifer Marshall; Mike R. Dyson; Peter Slavny; Kothai Parthiban; Aneesh Karatt-Vellatt; Ilfita Sahbudin; Eric Culbert; Patrick Hextall; Felix I.L. Clanchy; Richard Williams; Brian D. Marsden; Karim Raza; Andrew Filer; Christopher D. Buckley; John McCafferty; Kim S. Midwood

doi:10.1136/annrheumdis-2019-215108

Response to: Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al

Susan Aungier, Alison J. Cartwright, Anja Schwenzer, Jennifer Marshall, Mike R. Dyson, Peter Slavny, Kothai Parthiban, Aneesh Karatt-Vellatt, Ilfita Sahbudin, Eric Culbert, Patrick Hextall, Felix I.L. Clanchy, Richard Williams, Brian D. Marsden, Karim Raza, Andrew Filer, Christopher D. Buckley, John McCafferty, Kim S. Midwood^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	e43
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	4
DOIs	https://doi.org/10.1136/annrheumdis-2019-215108
Publication status	Published - 1 Apr 2020

Bibliographical note

Funding Information:
Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. KR, IS, AF and CDB were supported by the National Institutefor Health Research (NIHR) Birmingham Biomedical Research Centre.

Funding Information:
Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, Oxford OX3 7FY, UK; kim.midwood@kennedy.ox.ac.uk Handling editor Josef S Smolen Acknowledgements The authors would like to thank the Technology Hub Imaging Centre at the University of Birmingham. Contributors All authors reviewed the response. Funding This work was supported by grants from Nascient Ltd (SRA, AJC, FC and JLM), Arthritis Research UK Fellowships (20003: AS and KSM) and (18547: AF),and an Arthritis Research UK programme grant (19791: CDB). This work was also supported by the Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence (20298). BDM was supported by the SGC and by the Kennedy Trust for Rheumatology Research. This report includes independent research supported by the National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust.

Keywords

early rheumatoid arthritis
inflammation
treatment

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology
General Biochemistry,Genetics and Molecular Biology

Access to Document

10.1136/annrheumdis-2019-215108

Cite this

Aungier, S., Cartwright, A. J., Schwenzer, A., Marshall, J., Dyson, M. R., Slavny, P., Parthiban, K., Karatt-Vellatt, A., Sahbudin, I., Culbert, E., Hextall, P., Clanchy, F. I. L., Williams, R., Marsden, B. D., Raza, K., Filer, A., Buckley, C. D., McCafferty, J., & Midwood, K. S. (2020). Response to: Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al. Annals of the Rheumatic Diseases, 79(4), Article e43. https://doi.org/10.1136/annrheumdis-2019-215108

@article{48e5b37dddf0430dbf37a4288be7b31f,

title = "Response to: Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al",

keywords = "early rheumatoid arthritis, inflammation, treatment",

author = "Susan Aungier and Cartwright, {Alison J.} and Anja Schwenzer and Jennifer Marshall and Dyson, {Mike R.} and Peter Slavny and Kothai Parthiban and Aneesh Karatt-Vellatt and Ilfita Sahbudin and Eric Culbert and Patrick Hextall and Clanchy, {Felix I.L.} and Richard Williams and Marsden, {Brian D.} and Karim Raza and Andrew Filer and Buckley, {Christopher D.} and John McCafferty and Midwood, {Kim S.}",

note = "Funding Information: Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. KR, IS, AF and CDB were supported by the National Institutefor Health Research (NIHR) Birmingham Biomedical Research Centre. Funding Information: Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, Oxford OX3 7FY, UK; kim.midwood@kennedy.ox.ac.uk Handling editor Josef S Smolen Acknowledgements The authors would like to thank the Technology Hub Imaging Centre at the University of Birmingham. Contributors All authors reviewed the response. Funding This work was supported by grants from Nascient Ltd (SRA, AJC, FC and JLM), Arthritis Research UK Fellowships (20003: AS and KSM) and (18547: AF),and an Arthritis Research UK programme grant (19791: CDB). This work was also supported by the Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence (20298). BDM was supported by the SGC and by the Kennedy Trust for Rheumatology Research. This report includes independent research supported by the National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust.",

year = "2020",

month = apr,

day = "1",

doi = "10.1136/annrheumdis-2019-215108",

language = "English",

volume = "79",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "4",

}

Aungier, S, Cartwright, AJ, Schwenzer, A, Marshall, J, Dyson, MR, Slavny, P, Parthiban, K, Karatt-Vellatt, A, Sahbudin, I, Culbert, E, Hextall, P, Clanchy, FIL, Williams, R, Marsden, BD, Raza, K , Filer, A, Buckley, CD, McCafferty, J & Midwood, KS 2020, 'Response to: Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al', Annals of the Rheumatic Diseases, vol. 79, no. 4, e43. https://doi.org/10.1136/annrheumdis-2019-215108

TY - JOUR

T1 - Response to

T2 - Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al

AU - Aungier, Susan

AU - Cartwright, Alison J.

AU - Schwenzer, Anja

AU - Marshall, Jennifer

AU - Dyson, Mike R.

AU - Slavny, Peter

AU - Parthiban, Kothai

AU - Karatt-Vellatt, Aneesh

AU - Sahbudin, Ilfita

AU - Culbert, Eric

AU - Hextall, Patrick

AU - Clanchy, Felix I.L.

AU - Williams, Richard

AU - Marsden, Brian D.

AU - Raza, Karim

AU - Filer, Andrew

AU - Buckley, Christopher D.

AU - McCafferty, John

AU - Midwood, Kim S.

N1 - Funding Information: Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. KR, IS, AF and CDB were supported by the National Institutefor Health Research (NIHR) Birmingham Biomedical Research Centre. Funding Information: Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, Oxford OX3 7FY, UK; kim.midwood@kennedy.ox.ac.uk Handling editor Josef S Smolen Acknowledgements The authors would like to thank the Technology Hub Imaging Centre at the University of Birmingham. Contributors All authors reviewed the response. Funding This work was supported by grants from Nascient Ltd (SRA, AJC, FC and JLM), Arthritis Research UK Fellowships (20003: AS and KSM) and (18547: AF),and an Arthritis Research UK programme grant (19791: CDB). This work was also supported by the Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence (20298). BDM was supported by the SGC and by the Kennedy Trust for Rheumatology Research. This report includes independent research supported by the National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust.

PY - 2020/4/1

Y1 - 2020/4/1

KW - early rheumatoid arthritis

KW - inflammation

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85061531796&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2019-215108

DO - 10.1136/annrheumdis-2019-215108

M3 - Letter

C2 - 30755416

AN - SCOPUS:85061531796

SN - 0003-4967

VL - 79

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 4

M1 - e43

ER -